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Background: IDEFICS (Identification and Prevention of Dietary- and Lifestyle-Induced Health Ef-
fects in Children and Infants Project) is a Europeanmulticenter study on childhood obesity. One of
its goals is to define early biomarkers of risk associated with obesity and its comorbid conditions.
Objective:We considered blood cells as a new potential source of transcriptional biomarkers for
these metabolic disorders and examined whether blood cell mRNA levels of some selected genes
(LEPR, INSR, CPT1A, SLC27A2, UCP2, FASN, and PPAR) were altered in overweight children and
whether their expression levels could be defined asmarkers of the insulin-resistant or dyslipidemic
state associated with overweight.
Design: Blood sampleswere obtained from306normal-weight andoverweight children, aged 2–9 yr,
from eight different European countries. Whole-blood mRNA levels were assessed by quantitative
RT-PCR.
Results: LEPR, INSR, and CPT1A mRNA levels were higher in overweight compared with normal-
weight children (the two latter only in males), whereas SLC27A2mRNA levels were lower in over-
weight children. Significant associations were also found between expression levels of LEPR, INSR,
CPT1A, SLC27A2, FASN, PPAR, and different parameters, including body mass index, homeostasis
model assessment index, and plasma triglycerides and cholesterol levels. These associations showed
that high expression levels of CPT1A, SLC27A2, INSR, FASN, or PPARmay be indicative of a lower risk
for the insulin-resistant or dyslipidemic state associated with obesity, whereas low LEPRmRNA levels
appear as a marker of high low-density lipoprotein cholesterol, independently of body mass index.
Conclusions: These findings point toward the possibility of using the expression levels of these
genes in blood cells as markers of metabolic status and can potentially provide an early warning
of a future disorder. (J Clin Endocrinol Metab 97: E648–E652, 2012)
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Obesity in childhood has increased dramatically in thelast decades; so have the risks of associatedmedical
conditions, such as type 2 diabetes and cardiovascular
disease (1, 2). Because obesity is amultifactorial syndrome
influenced by genetic, epigenetic, environmental, and be-
havioral factors (3, 4) and is often resistant to therapy,
early prevention efforts are requested. Therefore, the identi-
fication of new early biomarkers of susceptibility is relevant
to intervenewith lifestyle and nutritional changes before the
disease ismanifested. In this sense,oneof theobjectivesof the
IDEFICS (IdentificationandPreventionofDietary- andLife-
style-InducedHealthEffects inChildren and Infants Project)
is to identify biomarkers of susceptibility and their associa-
tion with the development of overweight/obesity and meta-
bolic syndrome in European children (5, 6).
Previous studies in rats have pointed out the use of
blood cells as a robust model to study energy homeostasis
maintenance and its relationshipwithbodyweight control
(7–9), thus providing a potential tissue source to discover
novel biomarkers related with energy balance. The use of
blood cells for gene expression studies offers an advantage
over other human tissues because they are themost readily
accessible tissue and are therefore of great interest for clin-
ical studies and experimental research (7, 10).
Thus, the objective of this study was to evaluate, in
blood samples of a subsample of normal-weight and over-
weight children from the IDEFICS population, whether
the expression levels of selected genes involved in energy ho-
meostasis (LEPR, INSR,CPT1A, SLC27A2,UCP2,FASN,
andPPAR) are altered in the obese state, to identify poten-
tial markers of overweight development in children. Addi-
tionally, we sought to evaluate whether expression levels of
these genes are related with the insulin-resistant or dyslipi-
demic state associated with overweight.
Subjects and Methods
Subjects
IDEFICS is a large European multicenter study on childhood
obesity. Details of the general design and baseline survey char-
acteristics can be found elsewhere (11).
Subjects involved in this study were a subset of 306 children,
selected from those enrolled in the baseline survey (that included
more than 16,000 children). The subjects included were both
males and females, with normal weight and overweight, and
belonging to eight European countries geographically spread
across Europe: Germany (n 40), Hungary (n 29), Italy (n
43), Cyprus (n 41), Spain (n 37), Estonia (n 37), Sweden
(n 45), and Belgium (n 34). In all countries, approval from
the local ethical committees and parental consent was obtained.
Anthropometric measurements and biochemical
measurements
Children in the IDEFICS baseline survey participated in a
standardized physical examination. Collected anthropometric
data included body weight and height, waist and hip circumfer-
ence, and skin fold thickness measurement (at four body sites:
subscapular, biceps, triceps, and suprailiac). The body mass in-
dex (BMI) was calculated as weight (kilograms) divided by
height (meters) squared according to International Obesity Task
Force criteria (12). Details on the biological samples collected
during the IDEFICS survey have been described elsewhere in
detail (13).
Blood sampling and processing for gene
expression analysis
For each participant, a total of 2.5 ml peripheral blood was
collected under fasting conditions into PAXgene vacutainer
tubes (QIAGEN, Hilden, Germany) via antecubital fossa veni-
puncture, following themanufacturer’s instructions (QIAGEN).
Total RNA was isolated using the PAXgene blood RNA kit ac-
cording to the manufacturer’s instructions (QIAGEN). RNA
quality andpuritywereanalyzedby spectrophotometryusing the
Nanodrop ND-1000, and RNA integrity was confirmed using
agarose gel electrophoresis.
Real-time quantitative RT-PCR analysis
All primers were obtained from Sigma Genosys (Sigma-Al-
drich Quimica SA, Madrid, Spain). Quantitative RT-PCR was
performed as previously described (14).
The threshold cycle (Ct)was calculatedusing the instrument’s
software (StepOne Software version 2.0), and the relative ex-
pression ratio of a target gene was calculated based on the cor-
responding real-time PCR efficiency and Ct deviation of an un-
known sample vs. mean Ct of all samples and expressed in
comparison to a reference gene (15). Rplpo was chosen as ref-
erence gene because it has been validated for human studies (16).
Statistical analysis
ANOVA was used to determine differences between normal-
weight and overweight children and other factors (such as sex,
country, and gene expression category) with age as covariate. No
interaction between country and the other factors studied was
found.
Single differences between two groups were assessed by Stu-
dent’s t test. The association between BMI and gene expression in
total blood cells was assessed by age-adjusted partial correlation
analysis (first order). The median value of the distribution in the
overall group was selected as an arbitrary cut point to define gene
expression categories (subjects with a low or high expression of
LEPR, INSR, CPT1A, SLC27A2, FASN, and PPAR).
All the analyses were performed using SPSS version 18 for
Windows (SPSS, Chicago, IL). Threshold of significance was
defined at P  0.05.
Results
Characteristics of study subjects
A summary of the subject information is shown in
Table 1. Of the 306 children enrolled in the study, 274
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subjects were fully characterized. Weight categories were
definedaccording toCole et al. (12).Ofnote, despite being
very young, overweight children already showed signifi-
cant differences comparedwith normal-weight children in
parameters tested [higher sc fat, waist, waist to hip ratio,
systolic and diastolic blood pressure, and homeostasis
model assessment (HOMA) values] as well as exhibited
higher circulating concentrations of insulin, glucose, trig-
lycerides, low-density lipoprotein (LDL) cholesterol, and
lower high-density lipoprotein cholesterol.
Gene expression levels in total blood cells
Transcript levels of LepR were significantly higher in
blood cells from overweight compared with normal-
weight children (Table 1). Concerning INSR and CPT1A
transcripts, there was an interaction between gender and
BMI category (P  0.092 and 0.027, respectively, by
ANOVA); male overweight children presented higher ex-
pression levels, whereas no differences were found in fe-
male children. The transcript levels of SLC27A2 were
lower in both male and female overweight children com-
pared with normal-weight children. Transcript levels of
PPAR, FASN, andUCP2were not significantly different
between overweight and normal-weight children.
Association studies of gene expression with
anthropometric and biochemical parameters
of subjects
To examine the potential interaction between gene ex-
pression in blood cells and BMI, LDL cholesterol, triglyc-
erides, and HOMA index, subjects were subdivided into
categories according to gene expression levels (low vs.
high). When subjects were subdivided on the basis of
LEPR expression levels, normal-weight childrenwith low
expression levels ofLEPR exhibited higher levels of LDL-
cholesterol than normal-weight children with high levels
of LEPR transcripts, and similar to those found in over-
weight children (Fig. 1A). No significant differences were
found concerning LDL cholesterol levels in overweight
children in relation to their levels of LEPR transcripts.
Concerning triglyceride levels, overweight children
with high expression levels of INSR or CPT1A did not
show the increase in triglyceride levels associated with fat
TABLE 1. General characteristics, anthropometry, biochemical parameters, and gene expression levels in total blood
cells in the population analyzed in the study
Normal-weight (n  136) Overweight (n  138)
ANOVA
Males
(n  68)
Females
(n  68)
Males
(n  65)
Females
(n  73)
Age (yr) 6.6  0.2 6.6  0.2 7.1  0.2 7.1  0.2 W (P  0.004)
Weight (kg) 22.3  0.6 21.5  0.5 38.3  1.0 35.1  0.9 W (P  0.001), S (P  0.001)
Height (cm) 120  1 119  1 130  1 127  1 W (P  0.001), S (P  0.001)
BMI (kg/m2) 15.3  0.2 15.0  0.2 22.4  0.4 21.6  0.3 W (P  0.001)
sc fat (mm)a 22.4  0.7 26.5  1.1 67.0  3.4 66.6  2.9 W (P  0.001)
Waist (cm) 52.7  0.5 51.5  0.5 70.9  1.0 67.9  0.9 W (P  0.001), S (P  0.004)
Waist/hip ratio 0.87  0.01 0.85  0.01 0.90  0.01 0.89  0.01 W (P  0.001), S (P  0.029)
Systolic blood pressure (mm Hg) 103  1 98  1 108  1b 107  1b W*S (P  0.040)
Diastolic blood pressure (mm Hg) 64.1  1.0 62.3  0.8 67.0  0.9 66.6  0.8 W (P  0.001)
Glucose (mg/dl) 84  1 82  1 87  1 87  1 W (P  0.001)
Insulin (IU/ml) 4.31  0.40 4.18  0.33 8.22  0.56 9.53  0.78 W (P  0.001)
HOMA index 0.92  0.09 0.84  0.07 1.83  0.14 2.06  0.18 W (P  0.001)
Triglycerides (mg/dl) 47  3 46  3 52  5 64  5 W (P  0.003)
HDL cholesterol (mg/dl) 57  2 53  2 50  2 47  1 W (P  0.001), S (P  0.049)
LDL cholesterol (mg/dl) 92  5 95  6 104  4 105  3 W (P  0.013)
Total cholesterol (mg/dl) 155  4 159  4 157  4 164  4
Total/HDL cholesterol ratio 2.97  0.15 3.16  0.11 3.26  0.14 3.67  0.13 W (P  0.003), S (P  0.024)
mRNA levels (%)
LEPR 88.3  7.2 85.4  6.0 107.6  7.2 101.8  6.9 W (P  0.014)
INSR 86.8  5.6 96.7  6.8 108.7  7.2b 96.2  6.7
CPT1A 93.7  5.4 90.9  6.1 116.8  8.5b 84.6  5.8 W*S (P  0.027)
SLC27A2 108.6  8.2 93.7  8.1 73.7  5.6 81.1  7.7 W (P  0.003)
PPAR 99.2  5.9 96.6  6.1 104.0  6.0 97.0  5.5
FASN 92.9  4.6 96.4  5.7 107.5  6.6 93.7  5.5
UCP2 93.5  5.2 100.3  7.2 101.2  6.8 95.5  6.2
Data are presented as mean  SEM. Statistical analysis, W*S represents the interactive effect between BMI categories and sex (P  0.05, two-way
ANOVA); S represents the differences between males and females (P  0.05, two-way ANOVA); W represents differences between overweight
and normal weight (P  0.05, two-way ANOVA). All ANOVA were corrected for age. HDL, High-density lipoprotein.
a Subcutaneous fat represents the sum of four different skin folds (subscapular, biceps, triceps, and suprailiac).
b Differences between overweight and normal weight within the same sex (P  0.05, Student’s t test).
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accumulation (Fig. 1, B and C), and both normal-weight
and overweight children with high expression levels of
SLC27A2, FASN, or PPAR exhibited lower triglyceride
levels (Fig. 1, D–F).
Regarding HOMA index, the negative effect of being
overweight appears to be attenuated by high CPT1A
mRNA levels in male individuals and by high SLC27A2
mRNA levels in both males and females but with a more
marked effect in males (Fig. 1, G and H).
Discussion
For early detection and prevention of
overweight-associated diseases, it is nec-
essary to develop new early biomarkers.
Bloodcanbeeasilyobtainedfromhuman
subjects, and therefore gene expression
patterns in blood cells can be easily mea-
sured for screening purposes. Here, we
focus on the study of the expression of
genes related to glucose and lipid metab-
olism in total blood cells, to discover
novel biomarkers related to energy bal-
ance in children, because we postulate
thatbloodcell expressionpatternmayre-
flect the gene expression profile of key
tissues involved in energy metabolism,
such as the liver or the adipose tissue, as
previously pointed out (7).
Transcript levels of leptin and in-
sulin receptor were found to be over-
expressed in childrenwith overweight,
although in the case of INSR, the in-
crease was found only in male children.
Concerning LEPR, we found a negative
correlation (after correction for con-
founding factors BMI and age) between
the expression levels of LEPR in blood
cells and levels of cholesterol (both LDL
and total) (partial r  0.275 and
0.216, respectively, P  0.01). Note-
worthy, normal-weight children with
low levels of LEPR transcripts had sim-
ilar levels of LDL cholesterol as over-
weight children. Then, independently of
BMI, lower expression levels ofLEPR in
blood cells may reveal high LDL choles-
terol levels.With a similar pattern, INSR
transcript levels were negatively corre-
lated with triglycerides, after correction
for confounding factors BMI and age
(partial r0.266,P0.01),andwhen
individuals were classified by high and
low INSR expression, we found that
those overweight individuals with high expression levels of
this gene seem to be protected against the hypertriglyceride-
mia associated with obesity.
ConcerningCPT1A, we found that this gene was over-
expressed in males with overweight but not in females.
Higher expression levels ofCPT1A in blood cells have also
been described in diet-induced obese rats (9), and this gene
is also overexpressed in the liver of obesemale rats, but not
in females (17). Interestingly, and similarly to results ob-
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FIG. 1. Comparison of plasma LDL cholesterol (A) and triglyceride levels (B–F) and HOMA
index (G, H) in normal-weight and overweight children with low and high mRNA expression
levels of different genes in total blood cells. Results are mean  SEM. W*CAT, Interactive
effect between BMI categories and categories of gene expression (P  0.05, two-way
ANOVA); CAT, differences between groups divided by gene expression categories (P  0.05,
two-way ANOVA); W, differences between overweight and normal-weight (P  0.05, two-
way ANOVA); *, differences between low and high gene expression within a same BMI group
(P  0.05, Student’s t test). All ANOVA analyses were corrected for age.
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tained with INSR, overweight individuals with high ex-
pression levels of CPT1A in blood cells seem to be pro-
tected against the increase in plasma triglyceride levels
associated with body fat accumulation. In addition, we
found a negative correlation (after correction for BMI and
age) between CPT1A mRNA levels and HOMA index
only in male children (partial r  0.284, P  0.05).
Moreover, within overweight males, those with lower ex-
pression levels of this gene showed higher HOMA index
than those with higher expression levels. Then, CPT1A
expression levels in blood cells appear to be a goodmarker
for the insulin-resistant state associated with overweight/
obesity in male children.
SLC27A2 expression levels were lower in overweight
compared with normal-weight children. The decrease of
SLC27A2 expression levels in blood cells in obese children
together with the negative correlation coefficients found
between the expression of this gene in blood cells and BMI
(partial r0.214, P 0.01) make this gene a candidate
biomarker of obesity/overweight in children. In addition,
regardless of body weight, individuals with high mRNA
levels of SLC27A2 in blood cells displayed lower triglycer-
ide levels.Moreover,within overweight children, thosewith
lower expression levels of this gene exhibited higherHOMA
values than those with higher expression levels. Thus, low
expression levelsofSLC27A2 (asobservedforCPT1A) seem
to exacerbate the insulin-resistant state associated with ex-
cess fat accumulation, particularly in males.
Wedidnot finddifferencesbetweennormal-weight and
overweight children concerning the expression levels of
FASN and PPAR in blood cells, but curiously, children
with high mRNA levels of these genes in blood cells dis-
played lower triglyceride levels, regardless of bodyweight,
similarly to what was observed for SLC27A2.
Itmaybe interpreted from the findings of this study that
some overweight children may be at an early stage of the
pathogenesis of diabetes and dyslipidemia, and the ex-
pression levels of specific genes in blood cells couldbeused
asmarkers of bodymetabolic status, potentially providing
an earlywarning of future disorders. Further investigation
in longitudinal studies will help to determine later conse-
quences of these identified biomarkers.
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